NRX PHARMACEUTICALS, INC. — Key Metrics
8 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
EPS (Diluted)
$-1
Book Value Per Share
$0
Free Cash Flow Per Share
$-1
Cash Per Share
$0
Revenue Per Share
$0
OCF Per Share
$-1
Return on Equity↓-664.3pts
146.2%
Return on Assets↑+177.1pts
-344.7%
Return on Invested Capital↓-731.2pts
65.5%
Debt to Equity
-0.78
Current Ratio↓-88.7% -$2
0.31
Quick Ratio↓-88.7% -$2
0.31
Asset Turnover
0.15
Days Sales Outstanding
47.97
Days Payables Outstanding
3086.24
R&D / Revenue
308.3%
SBC / Revenue
18.6%
Capex / Revenue
1.4%
Working Capital↓-194.7% -$40M
$-20M
Net Current Asset Value↓-196.2% -$41M
$-20M
Invested Capital↓-176.6% -$37M
$-16M
OCF / Net Income↑+21.7% +$0
0.49
FCF / Net Income↑+21.7% +$0
0.49
Accruals Ratio (Sloan)↑+57.2pts
-112.0%
Net Debt↑+71.8% +$20M
$-8M
Net Debt / EBITDA↑+102.5% +$0
0.48
Interest Coverage↑+99.6% +$6K
-24.18
Cash Coverage↑+99.0% +$2K
-21.03
Capex Coverage
-7219.00
Tangible Common Equity↓-189.7% -$39M
$-19M
TCE / Total Assets↓-207.6pts
-144.0%
Goodwill / Total Assets
13.8%
NOPAT↑+86.0% +$79M
$-13M
Cash ROIC↓-256.3pts
72.1%
WC / Revenue
-1607.0%
Capex / D&A↓-100.0% -$1
0.00
Reinvestment Rate↓-14.2pts
-14.2%
Asset Growth vs Revenue Growth
-2.3%
Revenue 5Y CAGR
54.6%
Stock Price (FY-end)↓-94.3% -$45
$3
Market Cap
$730M
P/S Ratio
60261.40
P/B Ratio
98.53
P/TB Ratio
98.53
Enterprise Value
$720M
EV / Sales
60261.40
FCF Yield
-5.4%
Shareholder Yield
-0.5%
R&D Yield
2.3%
Capex Yield
0.0%
Shares Variation (YoY)
40.2%
Beta (5Y)↑+607.8% +$1
1.11
Cost of Equity↑+4.8pts
10.1%
Cost of Debt (after tax)
1.0%
52W High↓-99.2% -$622
$5
52W Low↓-96.6% -$43
$2
Trailing Return 1Y↑+159.9pts
79.5%
Trailing Return 5Y
-99.1%
F-Score (Piotroski)↑+33.3% +$1
4.00
Z-Score (Altman)
-10.77
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.